Apparatus, systems and methods for determining and displaying pre-event and post-event analyte concentration levels

Patent metadata

Field	Value
Publication number	US-9949672-B2
Application number	US-96357910-A
Country	US
Kind code	B2
Filing date	Dec 8, 2010
Priority date	Dec 17, 2009
Publication date	Apr 24, 2018
Grant date	Apr 24, 2018

Abstract

Embodiments of the invention provide apparatus, systems and methods wherein pre-event and post-event analyte concentration readings associated with an event are collected and processed to determine a numerical delta. The numerical delta may be displayed on a visual display to aid in a ready determination of the affect that the event (alone or in combination with medication and/or insulin dosages) had on the analyte concentration levels. Medication and/or insulin dosages may be displayed alongside the numerical delta to gauge immediate relationships between numerical delta, dosage and/or an associated event. Apparatus and systems for calculating and displaying the numerical delta are described, as are other aspects.

First claim

What is claimed is:

1. A method of identifying and displaying events using a graphical user interface on a blood glucose meter, the method comprising:
providing a blood glucose meter (BGM) including a processor and a display operable to present a graphical user interface (GUI);
measuring a pre-event glucose concentration reading from a blood glucose sensor and a post-event glucose concentration reading from a blood glucose sensor, both readings associated with a first event, using the BGM;
calculating a numerical delta between the pre-event glucose concentration reading and the post-event glucose concentration reading for the first event with the BGM; and
displaying on the GUI of the BGM a time graph including a representation of the first event occurring and the numerical delta associated with the first event wherein the numerical delta is displayed proximate to the representation of the occurrence of the first event to facilitate immediate visual evaluation of a relative magnitude of the numerical delta and an association with the first event, both indicating a significance of the first event.

2. The method of claim 1 further comprising displaying on the GUI, an insulin dose associated with the first event proximate to the representation of the occurrence of the first event along with the numerical delta.

3. The method of claim 1 further comprising:
determining if the numerical delta is within a predetermined acceptable range; and
indicating within the GUI that the numerical delta is within the predetermined acceptable range with a first indicator.

4. The method of claim 3 wherein the first indicator is selected from a group consisting of:
a first displayed color, and
a first displayed graphic.

5. The method of claim 1 further including providing an indicia in the GUI associated with the first event, the indicia designating the first event as unacceptable if a magnitude of the numerical delta exceeds a predetermined threshold value wherein the indicia includes at least one of a display color and a graphic.

6. The method of claim 1 wherein the first event is a meal event and the pre-event glucose concentration reading is a preprandial glucose concentration reading and the post-event glucose concentration reading is a postprandial glucose concentration reading.

7. The method of claim 1 wherein the first event is an exercise regimen.

8. The method of claim 1 further comprising:
measuring a second pre-event glucose concentration reading and a second post-event glucose concentration reading, both associated with an additional event, with the BGM; and
calculating a numerical delta between the second pre-event glucose concentration reading and the second post-event glucose concentration reading for the additional event with the BGM; and
displaying on the time graph in the GUI of the BGM a representation of the additional event occurring and a second numerical delta for the additional event wherein the second numerical delta is displayed proximate to the representation of the occurrence of the second event to facilitate immediate visual evaluation of a relative magnitude of the second numerical delta and an association with the second event, both indicating a significance of the second event.

9. The method of claim 1 wherein the GUI displays the pre-event glucose concentration level and the post-event glucose concentration level on a first axis against time on a second axis, and the numerical delta is displayed adjacent to a peak in the time graph of the glucose concentration level over time.

10. The method of claim 9 wherein an insulin dosage is also displayed adjacent to the peak in the time graph of the pre-event glucose concentration level and the post-event glucose concentration level.

11. The method of claim 1 wherein the numerical delta is normalized as against another measure associated with the first event.

Assignees

• Simmons David A
• Reynolds Jeffery S
• Ripley Paul M
• Telson Stanley A
• Ascensia Diabetes Care Holdings Ag

Inventors

• Simmons David A
• Reynolds Jeffery S
• Ripley Paul M
• Telson Stanley A

Classifications

• A63B2230/202

  glucose · CPC title

• A63B71/0619

  Displays, user interfaces and indicating devices, specially adapted for sport equipment, e.g. display mounted on treadmills · CPC title

• A61B5/743

  Displaying an image simultaneously with additional graphical information, e.g. symbols, charts, function plots · CPC title

• A63B2230/20

  blood composition characteristics · CPC title

• A61B5/14546

  for measuring analytes not otherwise provided for, e.g. ions, cytochromes · CPC title